OTS - Bosch developing COVID-19-(SARS-CoV-2) rapid testing kit for the Vivalytic platform
2020. March 26. 14:50
Waiblingen, Germany, 26 March, 2020 (APA/OTS) - Test delivers
reliable results at the point of care in less than 2.5 hours - One
of the world's first multiplex molecular diagnostic tests that can
identify COVID-19 and distinguish it from nine other respiratory
infections with similar symptoms, like influenza - The test meets
the requirements of the World Health Organization (WHO) and was
developed together with Randox Laboratories Ltd.
Bosch Healthcare Solutions is currently working on the
development of a COVID-19 rapid testing kit for the Vivalytic
platform and will launch this in April 2020. The Vivalytic VRI test
(Viral Respiratory Tract Infections) checks the patient's sample
for the SARS CoV-2 virus, which can lead to COVID-19, as well as
nine other possible viral respiratory diseases. To prevent the
continued rapid spread of COVID-19, it is necessary to identify
infectious patients with and without symptoms. With the Vivalytic
VRI test, physicians can quickly and efficiently distinguish
between different infections with very similar symptoms, like
influenza, and immediately begin the appropriate treatment. The
test delivers a reliable result based on WHO guidelines in less
than 2.5 hours at the point of care, i.e. in close proximity to
where the patient's sample was collected. This means a
time-consuming logistics chain, in which the samples have to be
transported, is no longer necessary.
"Together with our partner Randox, we have adapted the manual
COVID-19 test, which has existed just a few weeks, to the new,
fully automated Vivalytic platform from Bosch," said Marc Meier,
Managing Director of Bosch Healthcare Solutions GmbH. "Thanks to
the extensive expertise of both companies, we have succeeded in
developing an innovative test in a very short time, which can
contribute to curbing the global spread of the coronavirus."
The Vivalytic platform is so easy to use that it can be handled
in any clinic or medical practice without the need for laboratory
personnel: The sample is taken from the patient's nose or throat
using a swab and placed in the cartridge without any complex
preparation. The Vivalytic analyser then fully automatically
processes the cartridge, which already contains all the reagents
required for the test. Since the system in each cartridge is
isolated, the risk of infection during handling is minimized.
Vivalytic is a universal platform for molecular diagnostics
that can be used to perform various fully automatic laboratory
tests in a short time. The open design of the platform makes it
compatible with manual tests from various suppliers. The range of
available tests is expected to grow steadily, enabling physicians
to initiate successful therapies based on rapid diagnosis.
Picture is available at AP Images (http://www.apimages.com)
Press contact:
Thomas Berroth
Marketing & Communication
Thomas.berroth2@de.bosch.com
+4971181145599
www.bosch-vivalytic.com
-------------------------------------------------------------------
Az OTS internetes oldalán található hírek, közlemények, fotók a
forrásmegjelöléssel (OTS) szabadon és korlátozás nélkül
felhasználhatók. Továbbközlés esetén a közzétevő köteles az átvett
anyagot tartalmának torzítása nélkül, félreérthetőséget,
rosszindulatú következtetéseket kizáró, az eredeti
szövegkörnyezetnek megfelelő módon feldolgozni és megjelentetni.
Az OTS hírek nem képezik az MTI hírkiadás részét, az MTI által
szó szerint továbbított tartalomért minden esetben a beadó a
felelős.
© Copyright MTI nonprofit Zrt.
Az OTS szolgáltatással kapcsolatban további információt a
(06-1) 441-9050 telefonszámon vagy a ots@mti.hu elektronikus
levelező címen kaphat.